12883_2018_1145_MOESM2_ESM.pdf (145.71 kB)
Additional file 2: of Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsingâremitting multiple sclerosis at year 1
journal contribution
posted on 2018-09-14, 05:00 authored by Anthony Traboulsee, David Li, Mark Cascione, Juanzhi Fang, Fernando Dangond, Aaron MillerFigure S1. Incremental quarterly relapse count over 1Â year. (PDF 145 kb)